The 1st International Online Conference on Diseases
The 1st International Online Conference on Diseases
From the Molecular to the Clinical Perspectives
Event's Timezone: Central European Summer Time
12 May 2025
23 June 2025
4 September 2025
Rare Syndrome, Oncology, Gastroenterology, Cardiology, Neuro-psychiatric Disorders, Respiratory Diseases, Infectious Diseases, Nutritional Diseases
The IOCD 2025 is now OPEN for submissions!
Abstract submission deadline is 12 May 2025.
Submit your abstracts HERE.
Register for the conference HERE.
Stay Tuned!
We will update important announcements here.
Exciting Update:
ALL participants with accepted abstracts now have the opportunity to upload and display their posters in the Poster Gallery on the conference's website!
Replacing the live poster session, the poster gallery would be ‘LIVE’ throughout and available for viewing during and permanently after the event!
Click here for more information and instructions on the poster submission.
Welcome from the Chair
S2: Nutrition and dietetics;
S3: Immune and inflammatory diseases;
S4: Geriatrics;
S5: Cardiovascular diseases;
S6: Neuropsychiatric disorders;
S7: Endocrine and metabolic disorders.
Prof. Dr. Omar Cauli
Department of Nursing, University of Valencia, 46010 Valencia, Spain
Chair of the 1st International Online Conference on Diseases
Follow us on Social Media
Event Chair
Prof. Dr. Omar Cauli, MD, PhD, is a Full Professor and Director of Master in Nursing Oncology at the Department of Nursing, University of Valencia, Valencia, Spain. He is also an International Relations and Research Coordinator at the University of Valencia. His research interests include Aging, Biomarker Analysis, Neurodegenerative Diseases, Geriatric Assessment, Elderly, Sleep, Memory and Learning, Cognitive Decline, Mild Cognitive Impairment, Cognition Disorders, Geriatric Psychiatry.
Event Committee
Dr. Teng obtained her Ph.D. degree from McGill University, Quebec, Canada in 1987. She did two years postdoctoral work in the laboratory of Dr. James Scott in London, England where she studied molecular aspects of apolipoprotein B (apoB) gene regulation. Dr. Teng is an Adjunct Professor in the Center for Human Genetics at the Brown Foundation Institute of Molecular Medicine, and an Adjunct Faculty Member in the Department of Medicine at Baylor College of Medicine. Dr. Teng’s laboratory is interested in the discovery of mechanisms contributing to the complex process of atherosclerosis in humans and animal models and design and development of genetic and cell therapies for the treatment of atherosclerotic vascular disease.
Laboratoire Inflammation Tissus Epithéliaux et Cytokines (LITEC), Université de Poitiers, France
Charles Bodet is a Professor at the Faculty of Health and co-director of the Laboratory Inflammation, Epithelial Tissues and Cytokines at the University of Poitiers, France. His research interests include skin inflammation and infection, innate immunity, cellular response to pathogens, microbial pathogenesis and antiviral and immunomodulatory agents.
Center for Dementia Research, Nathan Kline Institute for Psychiatric Research, Orangeburg, USA,
Department of Psychiatry, New York University Grossman School of Medicine, New York, USA
Dr. Balapal Basavarajappa is a leading researcher in neuropsychiatric disorders, investigating the roles of endocannabinoids, synaptic plasticity, and epigenetics in brain function and disease. He serves as a Senior Scientist at the Nathan Kline Institute for Psychiatric Research (Center for Dementia Research, Orangeburg, NY) and a Research Associate Professor at NYU Grossman School of Medicine (Department of Psychiatry, New York, NY). His work bridges molecular mechanisms and behavior, focusing on Fetal Alcohol Spectrum Disorders (FASD), Alcohol Use Disorder (AUD), neurodegeneration, and cognitive deficits, with particular emphasis on gene regulation, learning/memory, and behavioral outcomes. By integrating interdisciplinary approaches, his research aims to identify novel therapeutic targets for brain disorders.
Department of Physiology. Faculty of Medicines, Universtity of Valencia, Valencia, Spain
In 1985, I graduated at the University of Valencia and in 1996 I finished my PhD in the Cytological Research Institute (IEC) looking for astrogliogenesis during brain development. In 1997, I spent three years at Hallamshire Hospital, Sheffield, UK, working in inflammation and regulation of IL-1 and IL-1 receptor. In 2000, I returned to Spain at Department of Physiology, Faculty of Medicine in University of Valencia until now. I was working in toxicity in developmental and neurodegenerative disease (such as Alzheimer’s disease and ELA) looking for oxidative stress and inflammation mechanisms. I have my own laboratory “FINEUROL” and I am working in neurodegeneration and neurodevelopment. I have lectures in the School of Medicine as a Professor.
neuroscience; neuroinflammation; Alzheimer's disease; ELA
Dr. Teresa Tsang is Echo-Cardiologist, Clinician Scientist, and Professor in the Division of Cardiology at UBC. She is the Director of Echo Lab at Vancouver General Hospital and UBC Hospital, and Director of UBC AI Echo Core Lab. She is Executive Director of Vancouver Coastal Health Research Institute. Her focused areas of clinical and research interests include artificial intelligence in echocardiography, atrial remodelling, atrial fibrillation and other age-related cardiac conditions, and advancing technologies to achieve health equity.
ANUT-DSM (Alimentaciò, Nutrició Desenvolupament i Salut Mental), Departament de Bioquímica i Biotecnologia, Universitat Rovira i Virgili, Spain,
4School of Health Sciences, Universidad International de La Rioja (UNIR), Spain
Dr. Julio Plaza-Diaz is a postdoctoral scientist at the Universitat Rovira i Virgili, Reus, Spain. His research focuses on the role of microbes in various diseases (autism spectrum disorder, breast cancer, among others), mechanisms of probiotic action, and omics and molecular technologies in nutritional and general studies. The results of its scientific production have been 121 peer-reviewed JCR publications (all indexed in JCR), with 82 papers in Q1 (67.8%), and 10 of them in D1. Sixty (60) of the total papers are the first/last or corresponding author. In addition, Dr. Plaza-Diaz has published 14 book chapters and 14 communications in conferences and congresses. The H-index is 37 with 6,294 citations (6,091 without self-citations) according to Web of Science (visited on April 10, 2025). At present, Dr. Plaza-Diaz holds three initial academic credentials, "Ayudante Doctor", "Contratado Doctor" and "Profesor de Universidad Privada" from ANECA (Spain).
Session Chairs
Dr. Michele Malaguarnera
Psychobiology Department, University of Valencia, Valencia, Spain; Nursing Department, University of Valencia, Valencia, Spain
michele.malaguarnera@uv.es
Prof. Dr. Michele Malaguarnera is a professor of Pathophysiology at the Department of Nursing and a researcher at the Department of Psychobiology at the University of Valencia, Spain. He holds a degree in Pharmacy and a Ph.D. in Neuropharmacology from the University of Catania, Italy. Dr. Malaguarnera has authored more than 100 scientific publications and has expertise in liver and brain diseases, with a focus on metabolic disorders such as obesity and dyslipidemia. His research explores the therapeutic effects of L-carnitine and its derivatives in metabolic and neurological disorders. Additionally, he has worked on the treatment and pathophysiological understanding of hepatic encephalopathy. In addition to his work on metabolic disorders, Dr. Malaguarnera is currently exploring new research directions, particularly the impact of social defeat on overall health and the bidirectional communication between the brain and other organs in both physiological and pathological states. His interdisciplinary approach integrates neuropharmacology, metabolic regulation, and psychobiology to uncover novel mechanisms and therapeutic targets that could improve patient outcomes in a variety of diseases.
Dr. Andrea Cabrera-Pastor
Pharmacology Department, University of Valencia, Valencia, Spain; Fundación de Investigación del Hospital Clínico Universitario de Valencia (INCLIVA), Valencia, Spain
andrea.cabrera@uv.es
Andrea Cabrera-Pastor, PhD in Medical Clinical Biochemistry and Immunology, is a Professor in the Department of Pharmacology at the University of Valencia and a researcher at the Hospital Clínico Universitario de Valencia (Spain). Her early research focused on elucidating the molecular mechanisms underlying learning ability and motor coordination in animal models of minimal hepatic encephalopathy. Subsequently, her research interests shifted towards investigating the role of extracellular vesicles in the induction of neuroinflammation and neurotransmission dysfunction, contributing to cognitive and motor impairments. Currently, her research is primarily dedicated to the characterization of extracellular vesicles as biomarkers of obesity-associated comorbidities and systemic inflammation, as well as their role as key mediators in intercellular and interorgan communication. Dr. Cabrera-Pastor is particularly interested in the development of innovative diagnostic strategies and therapeutic targets to improve the management of metabolic and endocrine disorders.
Dr. Veysel Tahan
Division of Gastroenterology, Northeast Ohio Medical University - Summa Health System, Akron, USA
Veysel.Tahan@vandaliahealth.org
Dr. Veysel Tahan is an Associate Professor of Medicine and Gastroenterology, American Board of Internal Medicine (ABIM) Board Certified in both Internal Medicine (ABIM-IM) and Gastroenterology (ABIM-GI). International European Board of Gastroenterology certified and also IM and GI Board Certified in Türkiye. He received his medical degree from Akdeniz University Faculty of Medicine, Türkiye. He completed his IM residency at Istanbul University Cerrahpasa Medical Faculty and GI fellowship at Marmara University. He moved to Pittsburgh, PA in 2008 for a 4-year of “Hepatocyte and Stem Cell Transplantation for Hepatology Diseases” program at the University of Pittsburgh. He completed a second GI fellowship program at the University of Iowa Hospitals & Clinics. Worked as a clinical faculty/professor at the University of Missouri-Columbia Division of Gastroenterology, MO, USA between 2015-2023. Currently and Associate Professor of Internal Medicine, Division of Gastroenterology, Northeast Ohio Medical University (NEOMED)- Summa Health System, Akron OH, USA since January 2023 and & Charleston Area Medical Center (CAMC), WV since May 2024. Mentor of American College of Gastroenterology (ACG) on Research Career, Academics, Clinical Career and Educational Career. Fellow of American College of Gastroenterology (FACG), American Society for Gastrointestinal Endoscopy (FASGE), American Gastroenterological Association (AGAF), American College of Physicians (FACP), and the European Section and Board of Gastroenterology & Hepatology (FESBGH). Member of the American Association for the Study of Liver Diseases (AASLD), & and Cell Transplant Society, Turkish Society of Gastroenterology, Turkish Association for Study of Liver Diseases, & Turkish Society of Endoscopy. Has >200 international publications. In the editorial or advisory board of 15 medical journals.
Registration
The registration for IOCD 2025 will be free of charge! The registration includes attendance to all conference sessions.
When registering with several people under the same registration, please do not use the same email address for each person, but their individual university email addresses. Thank you for your understanding.
Please note that the submission and registration are two separate parts. Only scholars who registered can receive a link to access the conference live streaming. The deadline for registration is 4 September 2025.
Instructions for Authors
The 1st International Online Conference on Diseases will accept abstracts only. The accepted abstracts will be available online on Sciforum.net during and after the conference.
Important Deadlines
Deadline for abstract submission: 12 May 2025.
Announcement of oral and poster abstract results: 23 June 2025. You will be notified of the acceptance of an oral/poster presentation in a separate email.
Abstract submissions should be completed online by registering with www.sciforum.net and using the "New Submission" function once logged into the system. No physical template is necessary.
1. The abstract structure should include Background; Methodology; Results; Conclusions sections of up to 300 words in length.
2. All abstracts should be submitted and presented in clear, publication-ready English with accurate grammar and spelling.
3. You may submit multiple abstracts. However, only one abstract will be selected for oral presentation.
4. The abstracts submitted to this conference must be original and novel, without prior publication in any journals or it will not be accepted to this conference.
1. The submitting author must ensure that all co-authors are aware of the contents of the abstract.
2. Please select only one presenter for each submission. If you would like to change the presenter after submission, please email us accordingly.
Oral Presentation and Slides Submission
The slot for the oral presentation is 15 mins. We advise that your presentation lasts for a maximum of 12 mins, leaving at least 3 mins for the Q&A session.
Authors are encouraged to prepare a presentation in PowerPoint or similar software, to be displayed online along with the abstract. Slides, if available, will be displayed directly on the website using the proprietary slide viewer at Sciforum.net. Slides can be prepared in exactly the same way as for any traditional conference where research results are presented. Slides should be converted to PDF format prior to submission so that they can be converted for online display.
Poster Gallery
Your poster submission should include the title, authors, contact details and main research findings, as well as tables, figures, and graphs where necessary.
- File format: PDF (.pdf).
- Size in pixel: 1,080 width x 1,536 height–portrait orientation.
- Size in cm: 60 width x 80 height–portrait orientation.
- Font size: ≥20.
- Maximum size: 250 M
You can use our free template to create your poster. The poster template can be downloaded here.
Step 1 https://sciforum.net/dashboard/author/submissions
Step 2 Choose the correct conference and submission id, click upload button
Step 3 Upload poster (not oral presentation slides) and click submit button
Certificates of Participation are available in your logged-in area on sciforum.net, under "My Certificates" after the conference
Copyright
MDPI, the publisher of the Sciforum.net platform, is an open access publisher. We believe authors should retain the copyright to their scholarly works. Hence, by submitting an abstract to this conference, you retain the copyright to the work, but you grant MDPI the non-exclusive right to publish this abstract online on the Sciforum.net platform. This means you can easily submit your full paper (with the abstract) to any scientific journal at a later stage and transfer the copyright to its publisher if required.
Publication Opportunities
Participants in this conference are cordially invited to contribute a full manuscript to the Special Issue published in Diseases (ISSN: 2079-9721, IF 2.9), with a 20% discount on the publication fee. Special Issue information will be updated after the conference. All submitted papers will undergo MDPI’s standard peer-review procedure. The abstracts should be cited and noted on the first page of the paper.
Please note if you have IOAP/association discounts, conference discounts will be combined with IOAP/association discounts. Conference discounts cannot be combined with reviewer vouchers.
All accepted abstracts will be published in the conference report of The 1st International Online Conference on Diseases in the Medical Sciences Forum (ISSN: 2673-9992), if you wish to publish an extended proceeding paper (4-8 pages), please submit it to the same journal after the conference. Publication of the proceedings will be free of charge.
Authors are asked to disclose that it is a proceeding paper of the IOCD 2025 conference paper in their cover letter. Carefully read the rules outlined in the 'Instructions for Authors' on the journal’s website and ensure that your submission adheres to these guidelines.
Proceedings paper submission deadline: 19 October 2025
-
Title
-
Full author names
-
Affiliations (including full postal address) and authors' e-mail addresses
-
Abstract
-
Keywords
-
Introduction
-
Methods
-
Results and Discussion
-
Conclusions
-
Acknowledgements
-
References.You can download the template for the proceeding paper here.
Event Awards
To acknowledge the support of the conference's esteemed authors and recognize their outstanding scientific accomplishments, we are pleased to announce that the conference will provide 6 awards including Best Oral Presentation Award and Best Poster Award.
The Awards
Number of Awards Available: 6
The Best Oral Presentation Award is given to the paper judged to make the most significant oral contribution to the conference.
The Best Poster Award is given to the submission judged to make the most significant and interesting poster for the conference.
There will be six winners selected for this award. The winner will receive a certificate and 200 CHF each.
Sponsors and Partners
For information regarding sponsorship and exhibition opportunities, please click here.
Organizers
Media Partners
Conference Secretariat
Ms. Kenna Zhang
Ms. Margaery Yan
Email: iocd2025@mdpi.com
For inquiries regarding submissions and sponsorship opportunities, please feel free to contact us.
